Cofactor Genomics
Cofactor Genomics specializes in predictive immune modeling to enhance precision medicine by addressing existing barriers in the field. The company focuses on advancing the use of multidimensional biomarkers as opposed to single-analyte biomarkers through sophisticated health expression models. Cofactor operates one of the first CAP-certified clinical RNA sequencing laboratories, which facilitates efficient and cost-effective clinical trials for its partners. Leveraging its expertise in molecular biology, informatics, and database management, Cofactor Genomics provides high-quality services tailored to the healthcare and pharmaceutical sectors. This includes the development of diagnostic assays that target oncologic, immunologic, and neurodegenerative diseases, thereby contributing to medical research and improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.